In vivo inhibition of tumor growth of B16 melanoma by recombinant interleukin 1β: II. Mechanism of inhibition: The role of polymorphonuclear leukocytes

This publication has 21 references indexed in Scilit:

• Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes
  Published by Elsevier ,2004
• In vivo inhibition of tumor growth of B16 melanoma by recombinant interleukin 1? I. Tumor inhibition parallels lymphocyte-activating factor activity of interleukin 1? proteins
  Cytokine, 1990
• Novel neutrophil-stimulating peptides
  Immunology Today, 1989
• Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity.
  The Journal of Experimental Medicine, 1988
• Cytostatic and tumoricidal activities of tumor necrosis factor-treated neutrophils
  Immunology Letters, 1988
• Effects of interleukin 1 on endocrine mechanisms
  Clinical Immunology Newsletter, 1987
• Neutrophil Emigration and Microvascular Injury
  Pathology and Immunopathology Research, 1987
• Defensins. Natural peptide antibiotics of human neutrophils.
  Journal of Clinical Investigation, 1985
• Monocyte and granulocyte-mediated tumor cell destruction. A role for the hydrogen peroxide-myeloperoxidase-chloride system.
  Journal of Clinical Investigation, 1982
• THE ROLE OF THE THYMUS IN DEVELOPMENT OF IMMUNOLOGIC CAPACITY IN RABBITS AND MICE
  The Journal of Experimental Medicine, 1962